Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | PLG | P00747 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147174 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7545025 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL1235539 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL1701715 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7545108 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL2822938 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7541388 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7548607 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL2128896 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL905418 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115739095-B | Preparation method and application of Ni-Co@C carbon core-shell hydrophobic nanoparticle catalyst | 合肥飞木生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115974886-A | Macrocyclic lactam compound containing dihydrobenzofuran skeleton and preparation method thereof | 国科大杭州高等研究院 | 2023-04-18 | — | — | CN | claimed |
| CN-115739095-A | Preparation method and application of Ni-Co @ C carbon core-shell hydrophobic nanoparticle catalyst | 合肥飞木生物科技有限公司 | 2023-03-07 | — | — | CN | claimed |
| EP-3532528-A1 | RENEWABLY DERIVED POLYAMIDES AND METHODS OF MAKING THE SAME | Elevance Renewable Sciences, Inc. (US) | 2019-09-04 | — | — | EP | claimed |
| CN-109843976-A | The polyamide and its manufacturing method obtained by renewable source | 埃莱万斯可再生能源科学股份有限公司 | 2019-06-04 | — | — | CN | claimed |
| WO-2018080869-A1 | RENEWABLY DERIVED POLYAMIDES AND METHODS OF MAKING THE SAME | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-05-03 | — | — | WO | claimed |
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. | 2025-09-18 | — | — | US | disclosed |
| EP-4519272-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| EP-4519259-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| US-20250019731-A1 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | AGAIN BIO APS (DK) | 2025-01-16 | — | — | US | disclosed |
| US-20240238423-A9 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. | 2024-07-18 | — | — | US | disclosed |
| US-11981952-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| EP-2046859-B1 | SHEET MOLDING COMPOUNDS (SMC), THICK MOLDING COMPOUNDS (TMC), AND BULK MOLDING COMPOUNDS (BMC) COMPRISING THERMOSETTING RESINS BASED ON RENEWABLE RESOURCES | POLYNT S P A (IT) | 2009-12-23 | — | — | EP | disclosed |
| EP-2124895-A2 | LIPIDS AND THEIR USE AS NON-VIRAL DELIVERY VEHICLE | IMUTHES LIMITED (GB) | 2009-12-02 | — | — | EP | disclosed |
| EP-2046859-A1 | SHEET MOLDING COMPOUNDS (SMC), THICK MOLDING COMPOUNDS (TMC), AND BULK MOLDING COMPOUNDS (BMC) COMPRISING THERMOSETTING RESINS BASED ON RENEWABLE RESOURCES | Polynt S.p.a. (IT) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008078102-A2 | LIPIDS AND THEIR USE AS NON-VIRAL DELIVERY VEHICLE | IMUTHES LIMITED (GB) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008014931-A1 | SHEET MOLDING COMPOUNDS (SMC), THICK MOLDING COMPOUNDS (TMC), AND BULK MOLDING COMPOUNDS (BMC) COMPRISING THERMOSETTING RESINS BASED ON RENEWABLE RESOURCES | POLYNT S.P.A. (IT) | 2008-02-07 | — | — | WO | disclosed |
| EP-1884531-A1 | Sheet molding compounds (smc) comprising thermosetting resins based on renewable resources | Lonza Compounds GmbH & Co. KG (DE) | 2008-02-06 | — | — | EP | disclosed |
| US-5468888-A | Lupane derivatives, their preparation and the pharmaceutical compositions which contain them | RHONE-POULENC RORER S.A. (FR) | 1995-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | TSHR 1330/4885PAOX 684/4885LMNA 3439/4885 |
| US-20240238423-A9 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | BCL2A1, BCL2L1, BCL3 | TSHR 4074/4885PAOX 2969/4885LMNA 1943/4885 |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | BCL2L1, BCL2, BCL2L10 | TSHR 3777/4885PAOX 1559/4885LMNA 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.